Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting
Author(s): de Oliveira Ferreira Anderson, Holandino Carla
Issue: Mar/Apr 2008 - Compounding Around the World
View All Articles in Issue
Page(s): 163-169
Download in electronic PDF format for $75
Abstract: Enteric coated capsules are characterized by their resistance to dissolution in low pH environments, such as the stomach, and by their rapid disintegration in a higher pH environment, such as the intestine. The surface of hard gelatin capsules is usually smooth and nonporous, which limits their coating efficiency. We developed a simple, quick, and easily reproducible compounding preparation method for enteric-release hard gelatin capsules. Twenty-two batches of 60 diclofenac sodium capsules each were prepared and then divided into three groups. Each group was submitted to a different coating process using a small-scale enteric coating machine and a coating process based on the atomization (spraying) of organic solutions of polymers. The results of dissolution testing were compared statistically within the groups and also with a reference drug control (Voltaren DR). Some of the batches in group I and all the batches in groups II and III met the pharmacopeial requirements for enteric release, in both acid and p
Related Keywords:
enteric release hard gelatin capsules, enteric coating, diclofenac sodium, pain relief, analgesia, analgesic, cellulose acetate phthalate, polymer coatings, methacrylic acid copolymer, formulation, dissolution, capsule sealing
Related Categories:
PAIN MANAGEMENT, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, TECHNOLOGY, QUALITY CONTROL, DOSAGE FORMS/DRUG CARRIERS
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting
de Oliveira Ferreira Anderson, Holandino Carla
|
Mar/Apr 2008
Pg. 163-169
|
The Basics of Compounding: Compounding Special Capsules
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 291-294
|
Basics of Compounding: Special Capsules
Allen Loyd V Jr
|
May/Jun 2016
Pg. 209-214
|
Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
|
Sep/Oct 2017
Pg. 418-425
|
Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release
Bogner Robin H, Szwejkowski Jessica, Houston Alana
|
Sep/Oct 2001
Pg. 401-405
|
Stability of Melatonin in an Extemporaneously Compounded Sublingual Solution and Hard Gelatin Capsule
Haywood Alison, Burrell Anthony, van Bred Karin, George Rani, Testa Chris, Norris Ross
|
Mar/Apr 2009
Pg. 170-174
|
Evaluation of the Physical-chemical Characteristics and Biopharmaceutical Performance of Dilu-Cap: A Complete Line of Excipients for Hard-shell Capsules
de Oliveira Ferreira Anderson, Polonini Hudson
|
Jul/Aug 2022
Pg. 283-291
|
Progesterone 100-mg Semisolid-Fill, Hard-Gelatin Capsules
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 396
|
Standard Operating Procedure for Quality Assessment of Special Hard-Gelatin Capsules
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 312-313
|
Rule of Sixes for Filling Hard-Shell Gelatin Capsules
Nash Robert A
|
Jan/Feb 1997
Pg. 40-41
|
Triple Estrogen 2.5-mg Semisolid-Filled Hard-Gelatin Capsules
Allen Loyd V Jr
|
May/Jun 1997
Pg. 187
|
Standard Operating Procedure for Quality Assessment of Powder-Filled, Hard-Gelatin Capsules
Allen Loyd V Jr
|
May/Jun 1999
Pg. 232-233
|
Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients
Zur Eyal
|
Jan/Feb 2013
Pg. 10-22
|
In Vitro Evaluation of Extemporaneously Compounded Slow-Release Capsules Containing Morphine Sulfate or Oxycodone Hydrochloride
Glowiak Dana L, Green Julie L, Bowman Bill J
|
Mar/Apr 2005
Pg. 157-164
|
In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules
Webster Kathy D, Al-Achi Antoine, Greenwood Robert
|
Sep/Oct 1999
Pg. 409-411
|
Compounding of Slow-release Niacinamide Capsules: Feasibility and Characterization
Radojkovic Branko, Milic Jela, Calija Bojan
|
Sep/Oct 2012
Pg. 434-437
|
Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products
Uttaro Elizabeth, Zhao Fang, Schweighardt Anne
|
Sep/Oct 2021
Pg. 364-371
|
The Influence of Polymers, Surfactants, and Other Excipients on Naproxen Sodium Release from Matrices Prepared and the Effect of These Additives on the Swelling Rate of the Tablet
Alhmoud Hassan, Akkam Yazan, Omari Derar, Alghananim Alaa, Melhem Mohammad Bani
|
Sep/Oct 2023
Pg. 431-439
|
Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 545
|
Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 547
|
Return to Top |